Author(s)

Su Chan Lee, Chang Hyun Nam, Hye Sun Ahn, Bo Hyun Hwang, Jong Won Kim, Ha Young Park

Joint & Arthritis Research, Department of Orthopaedic Surgery, Himchan Hospital, Seoul, Korea..

Purpose: To investigate the clinical characteristics of combined prophylaxis of rivaroxaban (Xarelto^?) and mechanical therapy (foot sole pump, antiembolism stocking) after total knee replacement arthroplasty, for prevention of deep vein thrombosis (DVT). Materials and Methods: The subjects of this study were 110 patients who underwent total knee replacement arthroplasty (TKA) between November 2011 and May 2012, and were prospectively evaluated. They consisted of 13 men (11.8%) and 97 women (88.2%) with the mean age of 68.7 years (±7.9). All of the patients received 10 mg of rivaroxaban once daily for 14 days from Day 1 postoperatively, and used an intermittent pneumatic compression (IPC) pump and compression stockings immediately after the operation. To determine the presence of postoperative DVT, clinical symptoms examination, D-dimer test, color Doppler ultrasound imaging were performed to analyze the risk factors of DVT events. Results: There were a total of 13 patients (11.8%) with DVT in the distal lower limbs among the entire 110 patients. At Day 4 after the operation, a statistically significant difference was seen only in femoral swelling of several clinical symptoms between DVT group and non-DVT group (p = 0.043). D-dimer tests showed no statistically significant difference between the two groups, however with the boundary value of 0.3 mg/L, diagnostic sensitivity, specificity, positive predictability and negative predictability were equivalent to 100%, 8.2%, 12.7% and 100%, respectively. There was no significant difference between the two groups in terms of well-known risk factors including age, gender, obesity, hypertension, diabetes, smoking, and anesthesia method, and no case of pulmonary embolism was observed. Conclusion: A combination of pharmacological therapy (rivaroxaban, Xarelto^?) and mechanical therapy (foot sole pump system) after TKA is considered effective for DVT prevention.

Deep Vein Thrombosis; Total Knee Replacement Arthroplasty; Rivaroxaban

S. Lee, C. Nam, H. Ahn, B. Hwang, J. Kim and H. Park, "The Clinical Characteristics of Combined Deep Vein Thrombosis Prophylaxis of Rivaroxaban and Mechanical Therapy after Total Knee Replacement Arthroplasty," Open Journal of Orthopedics, Vol. 3 No. 1, 2013, pp. 14-19. doi: 10.4236/ojo.2013.31004.